Quandelacy T, Holtz M, Franco-Paredes C

Idioma: Ingles.
Referencias bibliográficas: 10
Paginas: 117-119
Archivo PDF: 219.43 Kb.

RESUMEN

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med 2006;3:e297.

2. Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009;27:261-268.

3. Franco-Paredes C, Jacob JT, Stryjewska B, Yoder L. Two patients with leprosy and the sudden appearance of inflammation in the skin and new sensory loss. PLoS Negl Trop Dis 2009;3:e425.

4. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev 2006;19:338-381.

5. Jacob JT, Kozarsky P, Dismukes R, Bynoe V, Margoles L, Leonard M, et al. Five-year experience with type 1 and type 2 reactions in Hansen disease at a US travel clinic. Am J Trop Med Hyg 2008;79:452-454.

6. Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, et al. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg 2006;74:868-879.

7. Lee DJ, Li H, Ochoa MT, Tanaka M, Carbone RJ, Damoiseaux AB, et al. Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis 2010;201:558-569.

8. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, et al. Genomewide association study of leprosy. N Engl J Med 2009;361:2609-2618.

9. Modlin RL. The innate immune response in leprosy. Curr Opin Immunol 2010;22:48-54.

10. Montoya D, Modlin RL. Learning from leprosy: insight into the human innate immune response. Adv Immunol 2010;105:1-24.